Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders

Before the 1990s, treatment of psychoses centred on conventional agents whose tolerability was limited by extrapyramidal symptoms (EPS). The past decade has seen the emergence of newer generation of antipsychotic agents. These agents provide better negative symptom efficacy, less impaired cognition...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavda, R.K., Laxmi, L, Nair, B.S., Gandewar, K.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949931/
https://www.ncbi.nlm.nih.gov/pubmed/21408042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949931/
https://www.ncbi.nlm.nih.gov/pubmed/21408042

Ejemplares similares